| Dale Hursh, MD | |
|
2110 Harrisburg Pike, Suite 300, Lancaster, PA 17601-2644 | |
| (717) 544-3022 | |
| (717) 544-3021 |
| Full Name | Dale Hursh |
|---|---|
| Gender | Male |
| Speciality | Geriatric Medicine |
| Experience | 35 Years |
| Location | 2110 Harrisburg Pike, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831154178 | NPI | - | NPPES |
| 000718505 | Other | PA | HIGHMARK |
| 1417248 | Other | PA | AETNA-HMO |
| 2069914 | Other | PA | MERCY |
| 40246 | Other | PA | GEISINGER |
| 50055979 | Other | PA | CAPITAL BLUE CROSS |
| P002392 | Other | PA | GATEWAY |
| 080174701 | Other | PA | RR MEDICARE |
| 5495042 | Other | PA | AETNA-NON HMO |
| 001279338 0014 | Medicaid | PA | |
| 0555449000 | Other | PA | INDEPENDENCE BLUE CROSS |
| 2069914 | Other | PA | UNISON |
| 50055979 | Other | PA | KEYSTONE HEALTH PLAN CENTRAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QG0300X | Family Medicine - Geriatric Medicine | MD044649L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care, Inc. | Harrisburg, PA | Home health agency |
| Hospice And Community Care | Lancaster, PA | Hospice |
| Caring Hospice Services | Lancaster, PA | Hospice |
| Hospice For All Seasons, Llc | Grantville, PA | Hospice |
| Lancaster General Hospital | Lancaster, PA | Hospital |
| Landis Homes | Lititz, PA | Nursing home |
| Calvary Fellowship Homes Inc | Lancaster, PA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lancaster General Hospital | 1254240039 | 408 |
News Archive
Decision Resources Group finds that the entry of eleven novel therapies into the non-small-cell lung cancer (NSCLC) market will drive the market's growth from $5.4 billion in 2014 to $12.7 billion in 2024.
And in this political climate, the $210 billion price tag [to fix the physician payment system] will probably prevent a permanent solution this year. However, a longer term, interim fix and a primary care payment differential would be steps in the right direction (Dennis Mayeaux and Lori Parham, 9/13).
Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute identifies a substance released by pancreatic cancer cells that protect them from attack by immune cells called macrophages.
A team of researchers from the Yale University (United States) and a Spanish company have developed a system to detect the vapours emitted by human skin in real time. The scientists think that these substances, essentially made up of fatty acids, are what attract mosquitoes and enable dogs to identify their owners.
› Verified 3 days ago
| Entity Name | Lancaster General Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952392383 PECOS PAC ID: 0941103683 Enrollment ID: O20040309000916 |
News Archive
Decision Resources Group finds that the entry of eleven novel therapies into the non-small-cell lung cancer (NSCLC) market will drive the market's growth from $5.4 billion in 2014 to $12.7 billion in 2024.
And in this political climate, the $210 billion price tag [to fix the physician payment system] will probably prevent a permanent solution this year. However, a longer term, interim fix and a primary care payment differential would be steps in the right direction (Dennis Mayeaux and Lori Parham, 9/13).
Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute identifies a substance released by pancreatic cancer cells that protect them from attack by immune cells called macrophages.
A team of researchers from the Yale University (United States) and a Spanish company have developed a system to detect the vapours emitted by human skin in real time. The scientists think that these substances, essentially made up of fatty acids, are what attract mosquitoes and enable dogs to identify their owners.
› Verified 3 days ago
| Entity Name | Lancaster General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720430812 PECOS PAC ID: 1254240039 Enrollment ID: O20040414000606 |
News Archive
Decision Resources Group finds that the entry of eleven novel therapies into the non-small-cell lung cancer (NSCLC) market will drive the market's growth from $5.4 billion in 2014 to $12.7 billion in 2024.
And in this political climate, the $210 billion price tag [to fix the physician payment system] will probably prevent a permanent solution this year. However, a longer term, interim fix and a primary care payment differential would be steps in the right direction (Dennis Mayeaux and Lori Parham, 9/13).
Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute identifies a substance released by pancreatic cancer cells that protect them from attack by immune cells called macrophages.
A team of researchers from the Yale University (United States) and a Spanish company have developed a system to detect the vapours emitted by human skin in real time. The scientists think that these substances, essentially made up of fatty acids, are what attract mosquitoes and enable dogs to identify their owners.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dale Hursh, MD 2110 Harrisburg Pike, Suite 300, Lancaster, PA 17601-2644 Ph: (717) 544-3022 | Dale Hursh, MD 2110 Harrisburg Pike, Suite 300, Lancaster, PA 17601-2644 Ph: (717) 544-3022 |
News Archive
Decision Resources Group finds that the entry of eleven novel therapies into the non-small-cell lung cancer (NSCLC) market will drive the market's growth from $5.4 billion in 2014 to $12.7 billion in 2024.
And in this political climate, the $210 billion price tag [to fix the physician payment system] will probably prevent a permanent solution this year. However, a longer term, interim fix and a primary care payment differential would be steps in the right direction (Dennis Mayeaux and Lori Parham, 9/13).
Most cancer drugs are designed to target dividing cells, but a new study by Stony Brook University researchers suggests that targeting invasive cells may be a new strategy to treat metastatic cancer.
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute identifies a substance released by pancreatic cancer cells that protect them from attack by immune cells called macrophages.
A team of researchers from the Yale University (United States) and a Spanish company have developed a system to detect the vapours emitted by human skin in real time. The scientists think that these substances, essentially made up of fatty acids, are what attract mosquitoes and enable dogs to identify their owners.
› Verified 3 days ago
Jon David Lepley, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Duke St, Lancaster, PA 17602 Phone: 717-544-4950 | |
Dr. Lindsi Anne Dearment, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1871 Santa Barbara Dr Ste 1, Lancaster, PA 17601 Phone: 717-560-1970 Fax: 717-560-2278 | |
Emily Kirchner, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 555 N Duke St, Lancaster, PA 17602 Phone: 717-544-4940 | |
Dr. John T Cotter Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2207 Oregon Pike Ste 202, Lancaster, PA 17601 Phone: 717-560-6470 Fax: 717-560-6472 | |
Dr. Spencer D Phillips, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2113 Manor Ridge Dr, Lancaster, PA 17603 Phone: 717-517-7841 Fax: 717-517-7853 | |
Danielle J Miller, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3045 Marietta Ave, Lancaster, PA 17601 Phone: 717-898-2900 | |
Dr. Christine Janouschek, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 210 S Prince St, Lancaster, PA 17603 Phone: 717-393-7709 |